Skip to main content
Admissions guidance, study banks, and career tools — get started on Shalyam
Research News

Scientists Turn Probiotic Bacteria into Tiny Cancer-Fighting Factories

Mayur Tembhare
  1. Researchers at the University of Chicago engineered BifidoSumIL-2 to deliver SumIL-2 directly into pancreatic tumors.

  2. In animal models, this therapy slowed tumor growth by activating T cells that fight cancer.

  3. The effects became even stronger when combined with chemotherapy or immunotherapy.

  4. Bifidobacterium longum is a probiotic bacterium found in yogurt and other foods.

Scientists Turn Probiotic Bacteria into Tiny Cancer-Fighting Factories

Topic: Health

Researchers at the University of Chicago engineered a probiotic bacterium to deliver an immune-stimulating treatment directly into pancreatic tumors. In animal models, this therapy slowed tumor growth and became even stronger when combined with chemotherapy or immunotherapy.

Cancer immunotherapy has improved how doctors treat many types of cancer, but pancreatic cancer remains hard to beat. The problem is that the environment around pancreatic tumors blocks immune cells from attacking them effectively.

A team at the University of Chicago developed a new approach to overcome this challenge. They used BifidoSumIL-2, an engineered strain of Bifidobacterium longum, a probiotic bacterium found in yogurt and other foods. This bacterium was designed to carry an immune-stimulating treatment called SumIL-2 directly into tumors.

In animal models, the therapy slowed tumor growth by activating T cells that fight cancer. When combined with chemotherapy or immunotherapy, its effects became even stronger. The researchers hope this approach could provide a new way to improve how pancreatic tumors respond to treatment.

Why It Matters

Pancreatic cancer is a major health concern in India and around the world. If this new therapy becomes effective, it could save thousands of lives and give patients more options for treatment.

Key Facts

  • Researchers at the University of Chicago engineered BifidoSumIL-2 to deliver SumIL-2 directly into pancreatic tumors.
  • In animal models, this therapy slowed tumor growth by activating T cells that fight cancer.
  • The effects became even stronger when combined with chemotherapy or immunotherapy.
  • Bifidobacterium longum is a probiotic bacterium found in yogurt and other foods.
  • Pancreatic cancer is a major health concern in India and around the world.

Key Terms

Probiotic
A type of good bacteria that helps keep our gut healthy
T cells
Immune cells that help fight off infections, including cancer

Implications

Pancreatic cancer is a major health concern in India and around the world. If this new therapy becomes effective, it could save thousands of lives and give patients more options for treatment.

Source: https://www.sciencedaily.com/releases/2026/08/260816044830.htm

Journal reference:

  1. Jaehyun Lee, Kaiting Yang, Christina A. Nowicki, Wei Liu, Kangdi Li, Emile Naccasha, Zhichen Sun, Yang-Xin Fu, Hua Liang, Ralph R. Weichselbaum, Mark Mimee. Engineered probiotic Bifidobacterium for tumor-targeted pancreatic cancer therapy. Science Advances, 2026; 12 (30) DOI: 10.1126/sciadv.adz1388

Leave a comment

← All research

Get Exclusive Insights with Every Issue

Join Shalyam Newsletter

Stay ahead in education, research, and innovation—straight to your inbox.